First Trust NYSE Arca Biotechnology Index Fund
304 hedge funds and large institutions have $1.65B invested in First Trust NYSE Arca Biotechnology Index Fund in 2026 Q1 according to their latest regulatory filings, with 57 funds opening new positions, 104 increasing their positions, 72 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
44% more repeat investments, than reductions
Existing positions increased: 104 | Existing positions reduced: 72
19.04% more ownership
Funds ownership: 53.78% → 72.82% (+19%)
9% more funds holding
Funds holding: 278 → 304 (+26)
Holders
304
Holding in Top 10
2
Calls
$4.26M
Puts
$341K
Top Buyers
| 1 | +$726M | |
| 2 | +$49.2M | |
| 3 | +$27.5M | |
| 4 |
NP
Nilsine Partners
Greenwood Village,
Colorado
|
+$18.6M |
| 5 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
+$15.6M |
Top Sellers
| 1 | -$14.7M | |
| 2 | -$2.89M | |
| 3 | -$2.18M | |
| 4 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
-$1.9M |
| 5 |
SA
SFI Advisors
Montclair,
New Jersey
|
-$1.85M |
